Similarly, Zhang et al. showed that a combination of formononetin and temozolomide could produce synergistic effects in C6 glioma cells through upregulation of Bax and caspase-3/-9 expression while downregulating Bcl-2 and MMP-2/-9 expressions [79]. This evidence concerns the gene BCL2 and central nervous system cancer.